854 related articles for article (PubMed ID: 3021954)
21. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
22. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
Tiberi M; Magnan J
Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
[TBL] [Abstract][Full Text] [Related]
24. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM
NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
[TBL] [Abstract][Full Text] [Related]
25. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
Martin TJ; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326
[TBL] [Abstract][Full Text] [Related]
26. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
27. Opioid ligand binding sites in the spinal cord of the guinea-pig.
Zarr GD; Werling LL; Brown SR; Cox BM
Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
[TBL] [Abstract][Full Text] [Related]
28. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
29. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
Martin TJ; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
31. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
32. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
James IF; Goldstein A
Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor selectivity of peptide models of beta-endorphin.
Taylor JW; Kaiser ET
Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
[TBL] [Abstract][Full Text] [Related]
34. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
35. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
Michel ME; Bolger G; Weissman BA
Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
[TBL] [Abstract][Full Text] [Related]
36. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
[TBL] [Abstract][Full Text] [Related]
37. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
38. Temperature dependence of the binding of mu, delta and kappa agonists to the opiate receptors in guinea-pig brain.
Borea PA; Bertelli GM; Gilli G
Eur J Pharmacol; 1988 Feb; 146(2-3):247-52. PubMed ID: 2836208
[TBL] [Abstract][Full Text] [Related]
39. Traumatic injury alters opiate receptor binding in rat spinal cord.
Krumins SA; Faden AI
Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077
[TBL] [Abstract][Full Text] [Related]
40. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]